Damora Therapeutics, Inc. · NASDAQ:DMRA
Point72 Asset Management, L.P.'s stake in Damora Therapeutics, Inc. fell to 2.00% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Damora Therapeutics, Inc. fell to 2.00%, 1,193,708 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 1,193,708
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 2.00% | 1,193,708 |
| Point72 Capital Advisors, Inc. | 2.00% | 1,193,708 |
| Steven A. Cohen | 2.00% | 1,193,708 |
Source
Related
- Damora Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Damora Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Nov 13, 2025
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026